doi: 10.1021/jm00088a003.
Synthesis and antiviral activity of a series of HIV-1 protease inhibitors with functionality tethered to the P1 or P1' phenyl substituents: X-ray crystal structure assisted design
Affiliations
- PMID: 1588551
- DOI: 10.1021/jm00088a003
Item in Clipboard
Synthesis and antiviral activity of a series of HIV-1 protease inhibitors with functionality tethered to the P1 or P1' phenyl substituents: X-ray crystal structure assisted design
J Med Chem.
.
Abstract
By tethering of a polar hydrophilic group to the P1 or P1' substituent of a Phe-based hydroxyethylene isostere, the antiviral potency of a series of HIV protease inhibitors was improved. The optimum enhancement of anti-HIV activity was observed with the 4-morpholinylethoxy substituent. The substituent effect is consistent with a model derived from inhibitor docked in the crystal structure of the native enzyme. An X-ray crystal structure of the inhibited enzyme determined to 2.25 A verifies the modeling predictions.
Similar articles
-
Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays.Biochemistry. 1992 Jul 28;31(29):6646-59. doi: 10.1021/bi00144a004. Biochemistry. 1992. PMID: 1637805
-
HIV-1 protease inhibitors based on hydroxyethylene dipeptide isosteres: an investigation into the role of the P1' side chain on structure-activity.J Med Chem. 1992 May 15;35(10):1702-9. doi: 10.1021/jm00088a004. J Med Chem. 1992. PMID: 1588552
-
A series of potent HIV-1 protease inhibitors containing a hydroxyethyl secondary amine transition state isostere: synthesis, enzyme inhibition, and antiviral activity.J Med Chem. 1992 Jul 10;35(14):2525-33. doi: 10.1021/jm00092a002. J Med Chem. 1992. PMID: 1635054
-
Viral proteases as targets for chemotherapeutic intervention.Curr Opin Biotechnol. 1992 Dec;3(6):643-9. doi: 10.1016/0958-1669(92)90010-g. Curr Opin Biotechnol. 1992. PMID: 1369416 Free PMC article. Review.
-
Recent advances in the design of HIV proteinase inhibitors.Antiviral Res. 1992 Apr;17(4):265-78. doi: 10.1016/0166-3542(92)90022-w. Antiviral Res. 1992. PMID: 1642479 Review.
Cited by
-
A Convenient Enzymatic Route to Optically Active l-Aminoindan-2-ol: Versatile Ligands for HIV-1 Protease Inhibitors and Asymmetric Syntheses.Synthesis (Stuttg). 1997 May;1997(5):541-544. doi: 10.1055/s-1997-1235. Synthesis (Stuttg). 1997. PMID: 30393402 Free PMC article.
-
L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor.Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):4096-100. doi: 10.1073/pnas.91.9.4096. Proc Natl Acad Sci U S A. 1994. PMID: 8171040 Free PMC article.
-
3'-Tetrahydrofuranylglycine as a Novel, Unnatural Amino Acid Surrogate for Asparagine in the Design of Inhibitors of the HIV Protease.J Am Chem Soc. 1993 Jan 1;115(2):801-803. doi: 10.1021/ja00055a069. J Am Chem Soc. 1993. PMID: 30364398 Free PMC article.
-
Highly Enantioselective Aldol Reaction: Development of a New Chiral Auxiliary from cis-1-Amino-2-hydroxyindan.J Chem Soc Chem Commun. 1992;1992(22):1673-1674. doi: 10.1039/C39920001673. J Chem Soc Chem Commun. 1992. PMID: 30364406 Free PMC article.
-
SDZ PRI 053, an orally bioavailable human immunodeficiency virus type 1 proteinase inhibitor containing the 2-aminobenzylstatine moiety.Antimicrob Agents Chemother. 1995 Jul;39(7):1406-13. doi: 10.1128/AAC.39.7.1406. Antimicrob Agents Chemother. 1995. PMID: 7492076 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Chemical Information